Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
-
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
-
Apellis Announces Keli Walbert to Join the Board of Directors
-
ConnectOne Bancorp, Inc. to Host 2024 Fourth Quarter Results Conference Call on January 30, 2025
-
Charges brought against Aspo board member in the matter concerning Ramirent Plc have been withdrawn
-
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
-
EDAP Appoints Joshua H. Levine to Board of Directors
-
Share Buy-back programme at SP Group A/S
-
Constellation To Acquire Calpine; Creates America’s Leading Producer of Clean and Reliable Energy to Meet Growing Demand for Customers and Communities
-
BD Names Pamela Spikner as Chief Accounting Officer and Controller
-
KKR & Co. Inc. to Announce Fourth Quarter 2024 Results
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
-
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
-
Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors
-
Astronics Corporation Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 and Initiates Revenue Guidance for 2025
-
Lindsay Corporation Announces Quarterly Cash Dividend
-
Avery Dennison to Webcast Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Honda 2025 Motorsports Program Overview
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
INTEGRA ANNOUNCES LEADERSHIP TRANSITION
-
From the Tax Law Offices of David W. Klasing - What If You Didn't File Required IRS FBARs?
-
DDB Miner Introduces Efficient and Stable Cloud Mining Platform
-
Birkenstock Announces First Quarter 2025 (Ended December 31, 2024) Results Date and Conference Call and January Conference Participation
-
Atomera to Present at the 27th Annual Needham Growth Conference
-
Delta Air Lines Announces December Quarter and Full Year 2024 Financial Results
-
Quarterhill Awarded High-Speed Weigh-In-Motion Prescreening Contract in Belgium
-
Xenia Hotels & Resorts Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
OneMain Holdings Announces Date of Fourth Quarter 2024 Earnings Release and Conference Call
-
Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz
-
Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potenti
-
Auction result of Treasury Bonds - RIKB 27 0415 - RIKB 35 0917
-
Marqeta to Announce Fourth Quarter and Full Year 2024 Results on February 26, 2025
-
Global Blue Releases the Monthly Tax Free Shopping Business Update for December 2024
-
TOYOTA GAZOO Racing Exhibiting at Tokyo Auto Salon 2025
-
Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China
-
Tikehau Capital: Disclosure of Shares Repurchases From 03 January 2025 to 09 January 2025
-
Net Asset Value(s)
-
C4 Launches KOL Incubation School to Empower the Next Generation of Crypto Content Creators
-
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
-
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
-
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
-
16 Press Releases You Need to See This Week
-
Fineqia Ltd Reports 38.4% Increase in Digital Asset Blockchain Infrastructure AMC's Year-End Net Asset Value
-
Happy Belly's HEAL Wellness QSR Announces the Grand Opening of its Newest Location at the University of Alberta
-
FunEasyLearn Announces Gift Cards Just in Time for the Holiday Season
-
Maple Leaf Foods Lays Groundwork for Transformational Year Ahead
-
Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
-
EXEL Industries: Total number of voting rights and shares at 11.30.2024
-
Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
